WFA Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$5.59K Buy
193
+3
+2% +$74 ﹤0.01% 168
2025
Q2
$5.33K Sell
190
-1,328
-87% -$31K ﹤0.01% 178
2025
Q1
$42.1K Sell
1,518
-178
-10% -$4.66K 0.02% 109
2024
Q4
$45K Buy
1,696
+1,503
+779% +$40.8K 0.02% 119
2024
Q3
$5.59K Buy
193
+3
+2% +$88 ﹤0.01% 169
2024
Q2
$5.33K Sell
190
-1,328
-87% -$36.6K ﹤0.01% 179
2024
Q1
$42.1K Buy
1,518
+320
+27% +$8.88K 0.02% 110
2023
Q4
$34.5K Buy
1,198
+16
+1% +$484 0.02% 113
2023
Q3
$39.2K Buy
1,182
+2
+0.2% +$71 0.02% 106
2023
Q2
$43.3K Buy
1,180
+2
+0.2% +$78 0.03% 105
2023
Q1
$48.1K Buy
1,178
+1,002
+569% +$43.3K 0.03% 97
2022
Q4
$9.03K Buy
176
+1
+0.6% +$48 0.01% 159
2022
Q3
$7.65K Buy
175
+2
+1% +$97 0.01% 168
2022
Q2
$9.09K Buy
173
+1
+0.6% +$51 0.01% 152
2022
Q1
$8.9K Buy
172
+1
+0.6% +$52 0.01% 157
2021
Q4
$10.1K Buy
+171
New +$8.47K 0.01% 149

Other funds holding PFE

WFA Asset Management's PFE Position: Q3 2025 in Review

WFA Asset Management increased its Pfizer (PFE) stake by 1.6% in Q3 2025, buying an estimated $74 and bringing the position to 193 shares worth $5.59K. The position accounts for ﹤0.01% of the portfolio, ranked #168.

WFA Asset Management first reported a position in PFE in Q4 2021 and has held it in 16 quarters since. The position peaked at $48.1K in Q1 2023. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • WFA Asset Management held 193 shares of Pfizer worth $5.59K as of Q3 2025.
  • WFA Asset Management bought 3 Pfizer shares in Q3 2025, an estimated $74.
  • Pfizer made up ﹤0.01% of WFA Asset Management's portfolio in Q3 2025, its #168 holding.
  • WFA Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 16 quarters since.
  • WFA Asset Management's Pfizer position peaked at $48.1K in Q1 2023.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on WFA Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.